How has been the historical performance of the Kobo Biotech?

Answer:The historical performance of Kobo Biotech shows significant fluctuations in key financial metrics over the years.

Breakdown:
Kobo Biotech's net sales have seen a decline from Rs 403.66 crore in March 2013 to Rs 103.19 crore in March 2014. This drop is mirrored in total operating income, which also fell from Rs 403.66 crore to Rs 103.19 crore in the same period. The company's total expenditure, excluding depreciation, decreased from Rs 360.78 crore in March 2013 to Rs 108.80 crore in March 2014, leading to an operating profit (PBDIT) that shifted from a profit of Rs 43.24 crore to a loss of Rs 0.68 crore. Consequently, the profit before tax turned negative, dropping from Rs 14.87 crore in March 2013 to Rs -34.27 crore in March 2014, resulting in a profit after tax of Rs -34.82 crore. The earnings per share (EPS) reflected this downturn, falling from Rs 6.07 to Rs -15.47. On the balance sheet, total liabilities remained stable at Rs 411.68 crore, while total assets also held steady at Rs 411.68 crore. Cash flow from operating activities decreased significantly, from Rs 36.72 crore in March 2013 to Rs 6.72 crore in March 2014, contributing to a net cash outflow of Rs -10.84 crore. Overall, Kobo Biotech's financial performance in March 2014 indicates a challenging year marked by declining revenues and increasing losses.